TRI facility · TRI 2024 reporting year

Icp Construction

Total reported releases 6k lb more than doubled year over year (+88%). Total releases concentrations are up 22% since 2019.

150 DASCOMB RD, Andover, Massachusetts · 325510 · Chemicals · operated by Cpc Holding LLC

TOTAL RELEASES · 20192024
Bar chart of annual values from 2019 to 2024, in lb. Most recent year (2024): 6k.6k'19'20'21'22'23'246k
Anomaly engine

Notable Signals

No notable signals at this facility for the current reporting year. See chemicals and equity context below for the full picture.

Chemicals reported · most recent year

What This Facility Releases

RESPIRATORYCAS 107-21-1

Ethylene glycol

3k lb · +3% YoY

Ethylene glycol concentrations have fallen 33% since 2019.

RESPIRATORYCAS N090

Chromium and Chromium Compounds(except for chromite ore mined in the Transvaal Region)

3k lb · YoY

Chromium and Chromium Compounds(except for chromite ore mined in the Transvaal Region) volumes here are too small to anchor a multi-year trend; YoY movement is still shown above.

Equity context · ACS 2018-2022 block-group demographics

Who Lives Next To This Facility

Within 3 miles of this facility (19 Census block groups, population-weighted demographics): a population of 34,436. Why we surface this →

POPULATION SHARE
10.2%

Low-income

POPULATION SHARE
20.9%

People of color

POPULATION SHARE
4.9%

Under age 5

POPULATION SHARE
19.3%

Over age 64

Source: Census ACS 2018-2022 block-group demographics, population-weighted across the 3-mile buffer around this facility (from USEPA-clone/EJAM-open blockgroupstats). Indicator-level percentile and EJ-disparity scores are surfaced on the county page and the state page — they describe wider regional exposure burdens, not effects attributable to a single facility.

Source. EPA Toxics Release Inventory · retrieved 2026-05-07. Reporting year 2024. TRI is a federal public-domain dataset under 17 USC §105.

What this is not. TRI quantifies releases reported by the facility under EPCRA §313 — not ambient air or water concentrations measured at receptors. We do not attribute individual health outcomes to specific facilities; that exceeds what the data can support.